Tenderwize
Back to tender search

Open-House Discount Agreement Filgrastim

Techniker Krankenkasse·Hamburg, Germany·Deadline Apr 30, 2028 · 618 days left·Open·Supplies
Sign up to saveOpen documents
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-08 - Filgrastim

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

No guaranteed volume or revenue; agreements are non-exclusive and competitors may also join.

Only pharmaceutical entrepreneurs with own marketing authorization can participate; local distributors without such sta...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Supply of Filgrastim medicinal products to German statutory health insurance funds (Techniker Krankenkasse, HEK, hkk) under discount agreements.
  • Contract term: max. 24 months from 01.05.2026 to 30.04.2028.
Show full summary

Open-house procedure for discount agreements on the active substance Filgrastim (biologic) with German statutory health insurers. Contract conclusion possible at any time during the term (max. 24 months from 01.05.2026). No exclusivity, no individual negotiations. Eligibility is strictly limited to pharmaceutical entrepreneurs under § 4 Abs. 18 AMG with a valid marketing authorization for the offered medicinal products. The tender is not a public procurement under EU law but uses the TED form for transparency. No estimated value provided. No procurement documents analyzed.

Risks

No guaranteed volume or revenue; agreements are non-exclusive and competitors may also join.

Only pharmaceutical entrepreneurs with own marketing authorization can participate; local distributors without such sta...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Bidders must be pharmaceutical entrepreneurs (pharmazeutischer Unternehmer) per § 4 Abs. 18 AMG for the offered medicinal products.
  • Valid marketing authorization for the offered medicinal products according to § 21 Abs. 1 AMG (or equivalent right to market).
  • No grounds for revocation or suspension of authorization.

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria specified; any qualified supplier can join (open-house model).

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-House Discount Agreement Filgrastim

Conclusion of discount agreements for Filgrastim under § 130a Abs. 8 SGB V. Open-house procedure with uniform conditions, no exclusivity. Performance nationwide (Germany).

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Apr 2026 - Apr 2028

Category

Pharmaceutical products

Award Criteria

No award criteria specified; any qualified supplier can join (open-house model).

Deadline

Deadline Apr 30, 2028

Procurement Details

Publication date
18 Mar 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
192805-2026

Documents (1)

Procurement document 1

Similar tenders

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

France – Pharmaceutical products – 26-10 : ACCORD-CADRE DE FOURNITURE DE MÉDICAMENTS 2026

Aug 21

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9